Status:
COMPLETED
Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY)
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Veno Occlusive Disease, Hepatic
Sinusoidal Obstruction Syndrome
Eligibility:
All Genders
3-70 years
Phase:
NA
Brief Summary
ELASTOVOD is a prospective multicenter study, involving several centers of Onco-haematology in Italy. Investigators perform hepatic elastographic measurements (with Transient Elastography, ARFI or 2D-...
Detailed Description
Sinusoidal Obstruction Syndrome (SOS), also known as hepatic Veno-Occlusive Disease (VOD), is a life-threatening complication in patients undergoing Hematopoietic Stem Cells Transplantation (HSCT) for...
Eligibility Criteria
Inclusion
- male or female patients
- age between 3 and 70
- patients suffering from an onco-hematological disease that have an indication for either allogenic or autologous hematopoietic stem cells transplantation
- obtaining of informed consent
Exclusion
- pathological obesity (BMI \>40)
- pacemaker of implantable defibrillator
- presence of ascites at baseline
Key Trial Info
Start Date :
April 28 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
1101 Patients enrolled
Trial Details
Trial ID
NCT03426358
Start Date
April 28 2015
End Date
December 1 2021
Last Update
April 14 2022
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi.
Bologna, BO, Italy
2
Casa Sollievo della Sofferenza
San Giovanni Rotondo, Foggia, Italy
3
Azienda Ospedaliera "Card. G. Panico"
Tricase, Lecce, Italy
4
Istituto Clinico Humanitas
Rozzano, Milano, Italy